Study of JMKX003142 Injection in Chinese Healthy Subjects - Trial NCT06344533
Access comprehensive clinical trial information for NCT06344533 through Pure Global AI's free database. This Phase 1 trial is sponsored by Jemincare and is currently Not yet recruiting. The study focuses on Healthy Adult. Target enrollment is 78 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Jemincare
Timeline & Enrollment
Phase 1
Apr 10, 2024
May 30, 2025
Primary Outcome
Number of the Adverse Events that are related to the single dose treatment,Number of the Adverse Events that are related to the multiple dose treatment
Summary
To Evaluate the Safety, Tolerability, and Pharmacokinetic Characteristics of JMKX003142
 Injection Administered Randomly, Double-blind, Placebo-controlled, Single-ascending Dose and
 Multiple-ascending Doses in Chinese Healthy Adult Subjects
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06344533
Non-Device Trial